These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 1772533)

  • 1. Simultaneous delivery of valproic acid and glycine to the brain. Deamination of 2-propylpentylglycinamide by monoamine oxidase B.
    Yu PH; Davis BA
    Mol Chem Neuropathol; 1991 Aug; 15(1):37-49. PubMed ID: 1772533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Some pharmacological implications of MAO-mediated deamination of branched aliphatic amines: 2-propyl-1-aminopentane and N-(2-propylpentyl)glycinamide as valproic acid precursors.
    Yu PH; Davis BA
    J Neural Transm Suppl; 1990; 32():89-92. PubMed ID: 2128515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deamination of 2-propyl-1-aminopentane and 2-[(2-propyl)pentylamino] acetamide by amine oxidases: formation of valproic acid.
    Yu PH; Davis BA
    Prog Neuropsychopharmacol Biol Psychiatry; 1991; 15(2):303-6. PubMed ID: 1908106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 2-propyl-1-aminopentane, its deamination by monoamine oxidase and semicarbazide-sensitive amine oxidase, conversion to valproic acid and behavioral effects.
    Yu PH; Davis BA
    Neuropharmacology; 1991 May; 30(5):507-15. PubMed ID: 1865997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deamination of aliphatic amines by type B monoamine oxidase and semicarbazide-sensitive amine oxidase; pharmacological implications.
    Yu PH; Davis BA; Boulton AA; Zuo DM
    J Neural Transm Suppl; 1994; 41():397-406. PubMed ID: 7931256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formation of the neurotransmitter glycine from the anticonvulsant milacemide is mediated by brain monoamine oxidase B.
    Janssens de Varebeke P; Cavalier R; David-Remacle M; Youdim MB
    J Neurochem; 1988 Apr; 50(4):1011-6. PubMed ID: 3346666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is the oxidation of milacemide by monoamine oxidase a major factor in its anticonvulsant actions?
    O'Brien EM; Tipton KF; Strolin Benedetti M; Bonsignori A; Marrari P; Dostert P
    Biochem Pharmacol; 1991 Jun; 41(11):1731-7. PubMed ID: 2043162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The deamination of noradrenaline and 5-hydroxytryptamine by rat brain and heart monoamine oxidase and their inhibition by cimoxatone, toloxatone and MD 770222.
    Strolin Benedetti M; Boucher T; Fowler CJ
    Naunyn Schmiedebergs Arch Pharmacol; 1983 Aug; 323(4):315-20. PubMed ID: 6633672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SL25.1131 [3(S),3a(S)-3-methoxymethyl-7-[4,4,4-trifluorobutoxy]-3,3a,4,5-tetrahydro-1,3-oxazolo[3,4-a]quinolin-1-one], a new, reversible, and mixed inhibitor of monoamine oxidase-A and monoamine oxidase-B: biochemical and behavioral profile.
    Aubin N; Barneoud P; Carter C; Caille D; Sontag N; Marc C; Lolivier J; Gardes A; Perron C; Le Kim A; Charieras T; Pandini M; Burnier P; Puech F; Jegham S; George P; Scatton B; Curet O
    J Pharmacol Exp Ther; 2004 Sep; 310(3):1171-82. PubMed ID: 15178694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deamination of dopamine and its 3-O-methylated derivative by human brain monoamine oxidase.
    Roth JA; Feor K
    Biochem Pharmacol; 1978; 27(11):1606-8. PubMed ID: 697902
    [No Abstract]   [Full Text] [Related]  

  • 11. Studies on the selective inhibition of membrane-bound rat liver monoamine oxidase.
    Mantle TJ; Wilson K; Long RF
    Biochem Pharmacol; 1975 Nov; 24(22):2031-8. PubMed ID: 1212252
    [No Abstract]   [Full Text] [Related]  

  • 12. Deamination of 5-methoxytryptamine, serotonin and phenylethylamine by rat MAO in vitro and in vivo.
    Prozialek WC; Vogel WH
    Life Sci; 1978 Feb; 22(7):561-9. PubMed ID: 272480
    [No Abstract]   [Full Text] [Related]  

  • 13. The deamination of n-pentylamine by monoamine oxidase and a semicarbazide-sensitive amine oxidase of rat heart.
    Guffroy C; Fowler CJ; Strolin Benedetti M
    J Pharm Pharmacol; 1983 Jul; 35(7):416-20. PubMed ID: 6136581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deamination of beta-phenylethylamine by monoamine oxidase--inhibition by imipramine.
    Roth JA; Gillis CN
    Biochem Pharmacol; 1974 Sep; 23(18):2537-45. PubMed ID: 4412708
    [No Abstract]   [Full Text] [Related]  

  • 15. The disposition of valproyl glycinamide and valproyl glycine in rats.
    Blotnik S; Bergman F; Bialer M
    Pharm Res; 1997 Jul; 14(7):873-8. PubMed ID: 9244143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic and pharmacodynamic analysis of (E)-2-ene valproyl derivatives of glycine and valproyl derivatives of nipecotic acid.
    Bialer M; Kadry B; Abdul-Hai A; Haj-Yehia A; Sterling J; Herzig Y; Shirvan M
    Biopharm Drug Dispos; 1996 Oct; 17(7):565-75. PubMed ID: 8894115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deamination of aliphatic amines by monoamine oxidase A and B studied using a bioluminescence technique.
    Tenne M; Youdim MB; Ulitzur S; Finberg JP
    J Neurochem; 1985 May; 44(5):1373-7. PubMed ID: 3989535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The interactions of milacemide with monoamine oxidase.
    O'Brien EM; Tipton KF; McCrodden JM; Youdim MB
    Biochem Pharmacol; 1994 Feb; 47(4):617-23. PubMed ID: 8129740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on the subcellular localization of monoamine oxidase types A and B and its importance for the deamination of dopamine in the rat brain.
    Urwyler S; von Wartburg JP
    Biochem Pharmacol; 1980 Nov; 29(22):3067-73. PubMed ID: 6779822
    [No Abstract]   [Full Text] [Related]  

  • 20. Evidence for dopamine deamination by both type A and type B monoamine oxidase in rat brain in vivo and for the degree of inhibition of enzyme necessary for increased functional activity of dopamine and 5-hydroxytryptamine.
    Green AR; Mitchell BD; Tordoff AF; Youdim MB
    Br J Pharmacol; 1977 Jul; 60(3):343-9. PubMed ID: 890205
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.